2020.03.18.20038190v2.full.pdf
470.9 KB
💥 #مقاله_تخصصی
💥ریویوی ارزشمندی‌ست از پژوهشگران فرانسوی، با بررسی مطالعات چندین کشور
A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19
⚠️ preprint
MedRxiv
18 March 2020
#stem_cells_therapy
#lopinavir / #ritonavir
#chloroquine
#umifenovir
#hydroxychloroquine
#plasma_treatment
#favipiravir
#methylprednisolone
#remdesivir
🌱 به بهانۀ این مقاله، یادی کنم از یکی از نویسندگانش، پروفسور یزدان یزدان‌پناه که اکنون در بیمارستانی در پاریس که خود رئیس بخش عفونی‌اش است به دلیل ابتلا به کووید-۱۹ بستری است:
👈دربارۀ پروفسور یزدان‌پناه
🆘 نکات و هشدارهای کووید-۱۹:
@nouritazeh
💥ریویوی ارزشمندی‌ست از پژوهشگران فرانسوی، با بررسی مطالعات چندین کشور
A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19
⚠️ preprint
MedRxiv
18 March 2020
#stem_cells_therapy
#lopinavir / #ritonavir
#chloroquine
#umifenovir
#hydroxychloroquine
#plasma_treatment
#favipiravir
#methylprednisolone
#remdesivir
🌱 به بهانۀ این مقاله، یادی کنم از یکی از نویسندگانش، پروفسور یزدان یزدان‌پناه که اکنون در بیمارستانی در پاریس که خود رئیس بخش عفونی‌اش است به دلیل ابتلا به کووید-۱۹ بستری است:
👈دربارۀ پروفسور یزدان‌پناه
🆘 نکات و هشدارهای کووید-۱۹:
@nouritazeh
ciaa1177.pdf
1.3 MB
#مقاله_تخصصی
#Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial
OUP
12 August 2020
From April 18 to June 16, 2020, 647 patients were screened, 416 randomized, and 393
analyzed as mITT, MP in 194 and placebo in 199 individuals. SARS-CoV-2 infection was
confirmed by RT-PCR in 81.3%. Mortality at day 28 was not different between groups. A
subgroup analysis showed that patients over 60 years in the MP group had a lower mortality
rate at day 28. Patients in the MP arm tended to need more insulin therapy, and no difference was seen in virus clearance in respiratory secretion until day 7.
The findings of this study suggest that a short course of MP in hospitalized patients with
COVID-19 did not reduce mortality in the overall population.
@nouritazeh | @HealthNotes
#Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial
OUP
12 August 2020
From April 18 to June 16, 2020, 647 patients were screened, 416 randomized, and 393
analyzed as mITT, MP in 194 and placebo in 199 individuals. SARS-CoV-2 infection was
confirmed by RT-PCR in 81.3%. Mortality at day 28 was not different between groups. A
subgroup analysis showed that patients over 60 years in the MP group had a lower mortality
rate at day 28. Patients in the MP arm tended to need more insulin therapy, and no difference was seen in virus clearance in respiratory secretion until day 7.
The findings of this study suggest that a short course of MP in hospitalized patients with
COVID-19 did not reduce mortality in the overall population.
@nouritazeh | @HealthNotes